Tarsus Pharmaceuticals, Inc.
TARS
$79.44
-$0.53-0.66%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 26.78% | 17.79% | 36.64% | 28.11% | 28.38% |
| Total Receivables | 145.30% | 95.32% | 104.56% | 171.31% | 375.73% |
| Inventory | 34.79% | 76.45% | -32.98% | -15.67% | 18,873.33% |
| Prepaid Expenses | 209.27% | 388.50% | -11.82% | 86.20% | 16.78% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 40.49% | 30.85% | 41.10% | 39.27% | 37.74% |
|
|
|||||
| Total Current Assets | 40.49% | 30.85% | 41.10% | 39.27% | 37.74% |
| Net Property, Plant & Equipment | 280.91% | -18.98% | -8.36% | -14.40% | 15.72% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -11.22% | 113.96% | 114.65% | 115.31% | 115.96% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 83.34% | 86.68% | 333.64% | 372.77% | 189.92% |
| Total Assets | 42.06% | 31.35% | 43.37% | 42.00% | 40.24% |
|
|
|||||
| Total Accounts Payable | 51.56% | 5.34% | 48.28% | 56.08% | 158.28% |
| Total Accrued Expenses | 27.09% | 96.71% | 115.75% | 37.73% | 81.44% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -87.32% | -47.60% | -34.36% | 52.76% | 49.17% |
| Total Finance Division Other Current Liabilities | 148.24% | 185.53% | 166.71% | 580.54% | 500.79% |
| Total Other Current Liabilities | 148.24% | 185.53% | 166.71% | 580.54% | 500.79% |
| Total Current Liabilities | 77.70% | 75.01% | 102.94% | 118.25% | 183.32% |
|
|
|||||
| Total Current Liabilities | 77.70% | 75.01% | 102.94% | 118.25% | 183.32% |
| Long-Term Debt | 0.80% | 0.77% | 140.48% | 140.94% | 141.38% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 718.39% | -- | -- | -- | -25.61% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 43.70% | 30.32% | 113.71% | 122.56% | 153.93% |
|
|
|||||
| Common Stock & APIC | 31.14% | 30.41% | 30.96% | 32.36% | 37.90% |
| Retained Earnings | -24.08% | -29.33% | -37.43% | -47.23% | -66.26% |
| Treasury Stock & Other | -16.47% | 122.16% | 234.92% | 9,050.00% | 4,425.00% |
| Total Common Equity | 41.10% | 31.86% | 24.43% | 13.98% | 11.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 41.10% | 31.86% | 24.43% | 13.98% | 11.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 41.10% | 31.86% | 24.43% | 13.98% | 11.15% |
|
|
|||||